![]() |
市場調査レポート
商品コード
1792281
機械式人工呼吸器の市場レポート:製品タイプ別、インターフェース別、年齢層別、換気モード別、最終用途別、地域別、2025~2033年Mechanical Ventilators Market Report by Product Type, Interface, Age Group, Mode of Ventilation, End-Use, and Region 2025-2033 |
||||||
カスタマイズ可能
|
機械式人工呼吸器の市場レポート:製品タイプ別、インターフェース別、年齢層別、換気モード別、最終用途別、地域別、2025~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2~3営業日
|
世界の機械式人工呼吸器の市場規模は2024年に57億米ドルに達しました。IMARC Groupは、市場は2033年までに80億米ドルに達し、2025~2033年にかけて3.9%の成長率(CAGR)を示すと予測しています。この市場は、慢性閉塞性肺疾患(COPD)や呼吸器疾患の有病率の上昇、高血圧、糖尿病、心血管疾患を患う人の増加、非侵襲的でポータブルな機械式人工呼吸器の開発などの継続的な技術進歩が主な要因となっています。
慢性呼吸器疾患の増加
喘息、急性閉塞性肺疾患、肺炎などの慢性呼吸器疾患の症例の増加が、主に機械式人工呼吸器市場統計を牽引しています。さらに、世界中でCOVID-19パンデミックが発生したことで、死亡率、罹患率、ヘルスケアコストが増加し、これが市場の成長を促進しています。そのため、さまざまな医療機関が、呼吸器疾患の発生を最小限に抑えるための対策や感染予防に力を入れています。例えば、National Council on Agingのデータによると、不規則な呼吸と脳への酸素供給の減少を特徴とする閉塞性睡眠時無呼吸症候群(OSA)は、米国では約3,900万人の成人が罹患しており、世界全体では9億3,600万人が罹患していると推定されています。また、米国肺協会によれば、慢性閉塞性肺疾患(COPD)は米国における疾病別死因の第3位で、1,640万人以上が慢性閉塞性肺疾患と診断されています。
技術の進歩
人工呼吸器の携帯性、モード、ユーザーインターフェースの改良など、継続的な技術の進歩が機械式人工呼吸器市場を拡大しています。さらに、在宅医療という新たな動向により、家庭環境におけるポータブルでユーザーフレンドリーな機器の人気が高まっていることも、世界の市場を活性化しています。このほか、自動化機能と高度なモニタリング機能を備えたスマートな機械式人工呼吸器の導入も市場成長にプラスの影響を与えています。例えば、Max Ventilatorは、加湿器と酸素療法機能を備えた非侵襲性人工呼吸器を発表し、成人および新生児医療への応用の多様性を示しました。さらに、Nihon Kohden OrangeMed, Inc.は、非侵襲的で緊急時に呼吸サポートを提供するNKV-330人工呼吸器システムの米国FDA認可を取得しました。
政府のイニシアティブ
呼吸器疾患や早期発見・治療の重要性に対する認識を高めるための公衆衛生キャンペーンなど、各国の政府機関によるいくつかの政策やイニシアティブの開始は、機械式人工呼吸器市場の見通しにプラスの影響を与えています。これに加えて、最新かつ改良された機械式人工呼吸器の導入に向けた研究開発への規制当局による投資の増加も、市場拡大を後押ししています。さらに、医療インフラの進歩、医療従事者向けのトレーニングプログラムやセミナーの増加が、機械式人工呼吸器市場の収益をさらに押し上げています。例えば、CAIRE Inc.の携帯型酸素濃縮器FreeStyle Comfortはフランスとドイツで保険償還が認可され、患者のアクセスが向上しました。同社はこの発売により、酸素療法モダリティの製品ポートフォリオを拡大しました。さらに、CorVent MedicalはCEマークの承認を受け、欧州でRESPOND-19人工呼吸器の商業使用を開始しました。この新しいシステムは、使いやすく、重症患者の換気能力を柔軟に拡張できるように設計されており、病院は急性呼吸窮迫症候群(ARDS)に苦しむ重症患者の治療を改善することができます。
The global mechanical ventilators market size reached USD 5.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.0 Billion by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2025-2033. The market is primarily driven by the rising prevalence of chronic obstructive pulmonary disease (COPD) and respiratory disorders, the elevating number of individuals suffering from hypertension, diabetes, and cardiovascular diseases, and the continuous technological advancements, such as the development of non-invasive and portable mechanical ventilators.
Increasing Cases of Chronic Respiratory Conditions
The rising cases of chronic respiratory conditions, including asthma, acute obstructive pulmonary disease, and pneumonia are primarily driving the mechanical ventilators market statistics. Moreover, the outbreak of the COVID-19 pandemic across the globe had increased mortality, morbidity, and healthcare costs, which is propelling the market growth forward. Therefore, various medical facilities are focusing highly on control measures and infection prevention to minimize the cases of such respiratory diseases. For instance, the National Council on Aging data indicated that Obstructive Sleep Apnea (OSA), characterized by irregular breathing and reduced oxygen supply to the brain, affected about 39 million adults in the U.S. and an estimated 936 million globally. Additionally, as per the American Lung Association, chronic obstructive pulmonary disease (COPD) is the third leading cause of death by disease in the United States. More than 16.4 million people have been diagnosed with chronic obstructive pulmonary disease.
Technological Advancements
The ongoing technological advances, such as improved ventilator portability, modes, and user interfaces, are augmenting the mechanical ventilators market. Moreover, the growing popularity of portable and user-friendly devices in home settings, on account of the emerging trend of home-based medical care, is catalyzing the global market. Besides this, the introduction of smart mechanical ventilator variants with automated features and advanced monitoring capabilities is also positively influencing the market growth. For example, Max Ventilator introduced non-invasive ventilators featuring humidifiers and oxygen therapy capabilities, demonstrating versatility in applications for adult and neonatal care. Additionally, Nihon Kohden OrangeMed, Inc. received U.S. FDA clearance for the NKV-330 Ventilator System, which is non-invasive and provides respiratory support in emergencies.
Launch of Government Initiatives
The launch of several policies and initiatives by government bodies across countries, including public health campaigns to raise awareness about respiratory illnesses and the importance of early detection and treatment is positively influencing the mechanical ventilators market outlook. In addition to this, the inflating investments by regulatory authorities in research and development efforts for the introduction of the latest and improved mechanical ventilators are also propelling the market expansion. Moreover, the advancing healthcare infrastructures, along with the increasing number of training programs and seminars for medical professionals are further catalyzing the mechanical ventilators market revenue. For instance, CAIRE Inc.'s FreeStyle Comfort portable oxygen concentrator was authorized for reimbursement in France and Germany, enhancing patient access. The company extended its oxygen therapy modalities product portfolio through this launch. Furthermore, CorVent Medical received CE Mark approval and launched commercial use of its RESPOND-19 Ventilator in Europe. The novel system is designed for easy-to-use, flexible expansion of critical care ventilation capacity to allow hospitals to improve the treatment of critically ill patients suffering from acute respiratory distress syndrome (ARDS).
Intensive care ventilators are developed for usage in critical care settings, such as intensive care units (ICUs) and emergency departments. They are capable of offering an advanced respiratory support to patients with severe respiratory failure or other critical conditions. On the other hand, portable/ambulatory ventilators are designed for use outside of traditional hospital settings, including in-home care, ambulances, or other transport settings. They are smaller, lighter, and more portable than intensive care variants, making them suitable for use in various places.
Invasive ventilation typically comprises the insertion of a tube into the patient's airway, usually through the mouth or nose (endotracheal tube) or via a surgical opening in the neck (tracheostomy tube). This allows the ventilator to deliver air or oxygen directly into the lungs. Invasive ventilation is generally utilized for patients with severe respiratory failure or who are unable to breathe on their own. Moreover, non-invasive ventilation does not need the insertion of a tube into the airway of the individual. Instead, it uses a mask or similar device to deliver air or oxygen to the patient's lungs. Non-invasive ventilation is often used for patients with less severe respiratory failure or for patients who are able to breathe on their own but require the additional support.
Pediatric ventilators are specifically created for infants and children. They are smaller in size and have features that cater to the unique respiratory needs of pediatric patients. These devices often include specialized modes and settings to deliver the appropriate level of support for smaller lungs and airways. Besides this, adult ventilators are designed for use in adult patients. They are larger and more robust than pediatric derivatives and are capable of providing the higher tidal volumes and pressures demanded for adult respiratory support. On the other hand, geriatric patients, who are typically older adults, may require ventilator support, owing to age-related respiratory conditions or complications.
Combined mode of ventilation, also referred to as dual or hybrid mode, combines the aspects of volume and pressure ventilation. It allows the ventilator to adjust the inspiratory pressure to maintain a set tidal volume, providing a more flexible and adaptable ventilation. Moreover, in volume mode of ventilation, the ventilator supplies a set tidal volume to the patient with each breath. This mode is commonly used in patients with normal lung compliance or when precise control over tidal volume is required, such as in acute respiratory distress syndrome (ARDS). Besides this, in pressure mode of ventilation, the ventilator delivers a set inspiratory pressure to the individual, allowing for a more variable tidal volume based on the lung compliance and resistance of the patient.
In hospitals and clinics, mechanical ventilators are utilized in intensive care units (ICUs), emergency departments, operating rooms, and general wards to support patients with acute respiratory failure, respiratory distress, or other conditions that require assisted ventilation. Additionally, these devices are increasingly being used in homecare settings to provide long-term respiratory support to patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD), neuromuscular disorders, or spinal cord injuries. Furthermore, ambulatory care centers, also known as outpatient clinics or day surgery centers, may utilize mechanical ventilators for patients undergoing procedures that require sedation or anesthesia, including endoscopic procedures or minor surgeries.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
North America represents a significant region of the mechanical ventilators market overview, owing to its advanced healthcare infrastructure and the inflating medical expenditures of individuals. Besides this, the increasing focus of Europe on healthcare quality and patient safety is further catalyzing the market forward. Moreover, in the Asia Pacific region, the rising aging population is positively influencing the market growth. Besides this, the inflating medical care spending by individuals in Latin America and Middle East and Africa and the increasing awareness towards respiratory diseases are augmenting the market expansion. For instance, according to a report published by the Centers for Disease Control and Prevention (CDC), out of all the hospitalizations caused by COVID-19, over 53% of patients were admitted to the intensive care unit. Additionally, based on a research study by Silvio A. Namendys-Silva et al., published in Critical Care, in Mexico, about 15.3% of hospitalized patients require invasive mechanical ventilation (IMV), and 70.8% of patients receive invasive mechanical ventilation (IMV) outside the ICU.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the major market players in the Mechanical Ventilators industry include: